Fig. 26.1
Endoscopic images of a gastric cancer. White light a and chromoendoscopy with indigo carmine b show a shallow depressed lesion in the anterior wall of the antrum
What Techniques Improve EUS Imaging of the Stomach Wall?
EUS is performed with radial or linear echoendoscopes, some of which are equipped with special features, such as color and power Doppler [3, 4], contrast harmonic imaging [5, 6], and others [7, 8]. EUS typically produces high-frequency ultrasound between 5 and 20 MHz, which can generate a high-resolution image in the near field with a limited penetration depth ranging from 1–2 to 5–6 cm, depending on the ultrasound frequency.
In general, gastric EUS is performed with the patient in the left lateral position, usually under conscious sedation with benzodiazepines in conjunction with a central analgesic. Propofol has been used recently and is associated with very low complication rates [9–11]. Radial echoendoscopes generate radial images of 360° and are oriented perpendicular to the shaft axis of the instrument. In contrast, linear echoendoscopes produce images directed parallel to the shaft axis of the endoscope , allowing effective and safe performance of EUS-guided fine-needle aspiration (EUS-FNA) . In our personal experience, radial imaging offers a better view of the gastrointestinal wall and the structures surrounding the stomach, and it provides a complete scan, unlike the linear echoendoscope that requires rotating the scope manually 360 degrees to get a complete view. This is a matter of personal preference, and some endosonographers (especially in the Western Hemisphere) may prefer the linear instrument for initial staging with the idea that any lymph nodes or other lesions that need EUS-FNA can be targeted immediately without changing the scope. EUS with high-frequency ultrasound probes is especially useful for early gastric cancer as opposed to the radial or linear echoendoscopes that are used in imaging advanced gastric cancer. Therefore, the choice of staging method—echoendoscope or miniature probe EUS—may first depend on the estimation of tumor depth (T stage) from findings on upper endoscopy or other imaging modalities [12, 13].
Adherence to the following principles during EUS will help ensure clear images.
1.
Clean out the stomach for a better view. Stomach contents and mucus on the stomach wall should be removed as much as possible because floating debris will worsen the quality of the images and subsequently complicate interpretation of EUS images. For this purpose, upper endoscopy should be performed before EUS. Upper endoscopy also can help to define the gross appearance of the upper GI tract and confirm the location of the lesion.
2.
Instill water during EUS. Acoustic coupling of the ultrasound transducer to the GI wall requires application of fluid as an interface between the transducer and the wall. This can be accomplished either by using a water-filled balloon around the tip of the echoendoscope or by instilling water into the gastric lumen. Water should be de-aired because air bubbles will interfere with the acoustic shadow. In the standard left lateral position during endoscopy, the stomach is initially collapsed by aspiration, followed by instillation of 200–400 mL of water into the lumen up to the fundus. The examination is begun from the antrum, while the instrument is slowly withdrawn, and all areas of the gastric circumference are visualized as far as possible with perpendicular scanning.
3.
Sustain the position. Scanning should be performed perpendicular to the target lesions because an oblique image may be unclear and can over- or underestimate disease depth. The appropriate distance between target lesions and the transducer is 0.5–1.0 cm.
4.
Use high frequency for shallow lesions and low frequency for deeper lesions. High-frequency EUS (e.g., using a miniature 20-MHz probe) can provide high-resolution images. This is especially useful in evaluating shallow lesions that may be located within the mucosa or submucosa. On the other hand, high-frequency EUS cannot penetrate the stomach wall and is not compatible for evaluation of deep lesions or perigastric lesions (e.g., lymph nodes, ascites). Low-frequency EUS, both radial and linear, can evaluate lesions that lie in deep parts of the stomach wall as well as perigastric lesions.
5.
Utilize positioning during EUS to obtain better images. EUS of the stomach can be difficult, especially in the prepylorus, fundus, and angle of the stomach. Maintaining the water level and keeping the probe scanning perpendicular to the wall is sometimes difficult to achieve. In these instances, rotating the patient may help keep the water level constant, and pushing the scope in, pulling it out, and then rotating it may help achieve a perpendicular position. For a lesion in the upper body or fundus of the stomach, slight rotation to the prone position from the left lateral position may be helpful. With a lesion around the angle of the stomach, a supine position may facilitate visualization. With a lesion in the prepylorus, a right lateral position may help obtain clear EUS images.
Normal Gastric Wall Anatomy as Viewed by EUS
The gastric wall typically consists of five distinct layers by EUS using the echoendoscopes with 7.5–12 MHz [14–16]. The first two inner layers with high and low echogenicity represent the interface/superficial mucosa and deep mucosa/muscularis mucosa. The third hyperechoic layer corresponds to the submucosa, the fourth hypoechoic layer to the muscularis propria, and the fifth hyperechoic layer to the serosa, which usually is not easily distinguishable from the surrounding echo-rich tissue. Using higher frequency EUS miniprobes (12 to 20 MHz) and under optimal conditions, up to nine gastric wall layers can be identified. The surrounding organs, vessels, and other structures are important for diagnosis as well as for orientation (e.g., to determine tumor infiltration depth). These organs and other structures include the pancreatic body and tail, parts of the liver (especially the left lobe), parts of the left kidney and spleen, and vessels such as the aorta, vena cava (proximal stomach), celiac trunk, and the splenic and left renal veins. In everyday practice, both the water filling the lumen and balloon inflation methods can be combined for improved imaging.
Gastric Cancer Staging with EUS
What is the TNM Staging System for Gastric Cancer?
The classification systems of the American Joint Committee on Cancer (AJCC) and the International Union Against Cancer (UICC) are the staging classifications used most often in the USA and commonly used in Asian countries. The AJCC/UICC system is based on TNM: tumor (T), lymph node (N), and metastasis (M) (Table 26.1) [17].
Table 26.1
AJCC (American Joint Committee on Cancer)/UICC (International Union Against Cancer) TNM classification
Primary tumor (T) | |||
TX | Primary tumor cannot be assessed | ||
T0 | No evidence of primary tumor | ||
Tis | Carcinoma in situ: intraepithelial tumor without invasion of the lamina propria | ||
T1 | Tumor invades lamina propria, muscularis mucosae, or submucosa | ||
T1a | Tumor invades lamina propria or muscularis mucosae | ||
T1b | Tumor invades submucosa | ||
T2 | Tumor invades muscularis propria | ||
T3 | Tumor penetrates subserosal connective tissue without invading visceral peritoneum or adjacent structures | ||
T4 | Tumor invades serosa (visceral peritoneum) or adjacent structures | ||
T4a | Tumor invades serosa (visceral peritoneum) | ||
T4b | Tumor invades adjacent structures | ||
Regional lymph nodes (N) | |||
NX | Regional lymph node(s) cannot be assessed | ||
N0 | No regional lymph node metastasis◊ | ||
N1 | Metastasis in 1–2 regional lymph nodes | ||
N2 | Metastasis in 3–6 regional lymph nodes | ||
N3 | Metastasis in 7 or more regional lymph nodes | ||
N3a | Metastasis in 7–15 regional lymph nodes | ||
N3b | Metastasis in 16 or more regional lymph nodes | ||
Distant metastasis (M) | |||
M0 | No distant metastasis | ||
M1 | Distant metastasis | ||
Anatomic stage/prognostic groups | |||
Stage 0 | Tis | N0 | M0 |
Stage IA | T1 | N0 | M0 |
Stage IB | T2 | N0 | M0 |
T1 | N1 | M0 | |
Stage IIA | T3 | N0 | M0 |
T2 | N1 | M0 | |
T1 | N2 | M0 | |
Stage IIB | T4a | N0 | M0 |
T3 | N1 | M0 | |
T2 | N2 | M0 | |
T1 | N3 | M0 | |
Stage IIIA | T4a | N1 | M0 |
T3 | N2 | M0 | |
T2 | N3 | M0 | |
Stage IIIB | T4b | N0 | M0 |
T4b | N1 | M0 | |
T4a | N2 | M0 | |
T3 | N3 | M0 | |
Stage IIIC | T4b | N2 | M0 |
T4b | N3 | M0 | |
T4a | N3 | M0 | |
Stage IV | Any T | Any N | M1 |
The final pathological staging will be determined by the surgically resected specimen. However, the initial staging is critical because of its importance in determining treatment strategy. Early stage patients may be eligible for endoscopic resection, which is discussed in more detail in the following section. Patients in stages I to III by preoperative staging may be good candidates for surgical resection [18–20]. Furthermore, patients with higher stage (T2 and above) tumors or suspected nodal involvement may benefit from neoadjuvant (preoperative) and/or adjuvant (postoperative) therapies in addition to surgery. Therefore, multidisciplinary evaluation is necessary to identify the best treatment strategy. On the other hand, patients with distant metastasis will receive less benefit from surgical resection than patients in earlier stages. Systemic therapy and/or palliative therapy may be indicated for these patients.
What Are the Indications for Endoscopic Resection?
It is also important to understand the indications for endoscopic treatment, including endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) for early-stage gastric cancer . According to Japanese gastric cancer treatment guidelines established in 2010, patients who have a T1a (mucosal) lesion and meet the following criteria discussed below can be managed endoscopically because the risk of lymph node metastasis is low and the prognosis is similar to patients who undergo surgical resection [19].
Definite Indication for Endoscopic Resection of Gastric Cancer
In Japan, EMR or ESD is a standard treatment for differentiated adenocarcinoma without ulcerative findings [UL (-)], a depth of invasion clinically diagnosed as T1a, and a tumor diameter less than 2 cm.
Expanded Indication for Endoscopic Treatment for Gastric Cancer
Tumors in the following categories have a very low probability of lymph node metastasis. Endoscopic resection for these tumors is regarded as an investigational treatment. ESD, but not EMR, should be employed. Tumors clinically diagnosed as T1a and one of the following characteristics: (a) differentiated, UL (-), but more than 2 cm in diameter; (b) differentiated, UL (-), and less than 3 cm in diameter; and (c) undifferentiated, UL (-), and less than 2 cm in diameter.
T staging by EUS
EUS can determine T staging by detecting tumor infiltration in the deepest part of the affected gastric wall. In general, gastric cancer has less echogenicity than does the surrounding normal tissue. Depending on the tumor stage, as the cancer grows, it destroys the normal gastric wall structure from the mucosal layer and eventually infiltrates other structures (Fig. 26.2).
Fig. 26.2
Endoscopic ultrasound evaluation of the depth of gastric cancer. a Normal gastric wall consists of five distinct layers. b Cancers limited to the mucosa show irregularity in the first and second layers, but the third layer is intact. c Submucosal invasion displays irregularity of the third layer. d Muscularis propria invasion shows interruption of the third layer. e Interruption of the fifth layer indicates that the invasion is deeper than the subserosal layer